Veracyte stands out in a pressured medical instruments industry as genAI adoption and rising sales forecasts fuel investor interest.
VCYT, IDXX and ISRG ride on genAI-powered growth as medical instruments evolve, even with weak industry returns and cost pressures.
Wall Street awaits Fed Chair Powell and counterparts at ECB forum Mortgage demand rises for a 3rd straight week 10-year Treasury yield down 1.9 bps to 3.745% The artificial intelligence trade had a ...
From transparency to data governance, learn what safeguards are critical to ensure that generative AI delivers safe, trusted ...